Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Alteral Therapeutics ApS
APS
Active
Advertising protection
CVR 43730967
Bakkevej 41, 3450
Allerød
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2022 · 3 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Alteral Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Income statement
DKK thousands
Item
2023
2024
Gross profit
—
—
Staff expenses
-0
-0
EBITDA
-79
-6
Depreciation & amort.
-0
-0
EBIT
-79
-6
Net financials
373
26
Profit before tax
294
20
Tax
-0
-0
Net profit
294
20
Balance sheet
DKK thousands
Item
2023
2024
Total assets
416
403
Equity
334
355
Long-term debt
0
0
Short-term debt
82
48
Total debt
82
48
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-557400.0%
This company
2023
2024
Equity ratio
88.0%
This company
38.2%
Market median
+130% vs market
2023
2024
Return on equity
5.7%
This company
18.4%
Market median
-69% vs market
2023
2024
Net profit margin (of gross profit)
2013700.0%
This company
2023
2024
Asset turnover (of gross profit)
0.00×
This company
2023
2024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-12-22 – 2023-12-31
View
PDF
More on Alteral Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
